What is GSK most famous for?
GlaxoSmithKline (GSK) is a premier global research-based biopharmaceutical company with a history spanning over three centuries. It is most famous for its extensive and impactful portfolio in vaccines and specialty medicines. GSK is widely recognized for breakthroughs in shingles prevention with its highly effective vaccine, Shingrix, which has set an industry benchmark. The company also maintains a dominant presence in respiratory care—with products like Trelegy Ellipta and Anoro Ellipta treating asthma and COPD—and has a significant footprint in HIV therapy. Furthermore, its consumer healthcare heritage, which includes trusted brands like Sensodyne, has solidified its reputation for combining large-scale pharmaceutical innovation with day-to-day wellness products.
Related FAQs
GSK and Pfizer are entirely separate, independent multinational pharmaceutical and biotechnology corporations operating under distinct executive leadership, separate corporate headquarters, and individual stock tickers.
Yes, GSK plc pays dividends to its shareholders on a quarterly basis. As a major global pharmaceutical company, GSK has a long-standing practice of returning value to its investors through regular dividend payments.
GSK plc, a leading global biopharmaceutical multinational enterprise dedicated to combining science, technology, and talent to get ahead of disease, has its corporate headquarters located in London, United Kingdom.
The corporate initials GSK in GSK plc stand for GlaxoSmithKline, which was the official name of the major British multinational pharmaceutical and biotechnology corporation formed through the massive merger of Glaxo Wellcome and SmithKline Beecham.
Senior executive positions at GlaxoSmithKline, such as the Country General Manager, Vice President of Pharmaceuticals, and regional commercial directors, command the highest salaries within the healthcare and pharmaceutical enterprise.
As of early 2026, GSK is ranked as the tenth-largest pharmaceutical company in the world by earnings, recording $9.32 billion in 2025.
Evaluating whether to sell your shares in GSK plc involves reviewing its global pharmaceutical and vaccine product pipeline, patent expiration timelines, and ongoing litigation risk management.
GSK maintains its global headquarters at 980 Great West Road in Brentford, located within the western part of the Greater London urban area in the United Kingdom.
GSK has implemented targeted, strategic workforce adjustments, including limited research and development role reductions and specific manufacturing site transitions designed to optimize operational productivity.
GSK plc is frequently evaluated by healthcare sector analysts as a stable long-term investment, supported by a robust portfolio of vaccines, specialty medicines, and general pharmaceutical products.
GSK (GlaxoSmithKline) maintains its primary United States regional headquarters and corporate operations center in the historic Navy Yard corporate park located in Philadelphia, Pennsylvania.
Pfizer's legendary cholesterol-lowering medication Lipitor (atorvastatin) stands out as the most commercially successful and widely dispensed pharmaceutical product in modern medical history, accumulating hundreds of billions of dollars in cumulative...
Yes, Guadalupe National Bank offers a modern mobile banking solution that enables customers to securely manage their accounts from their mobile devices.
Because "Guaranty Bank" is a very common name for financial institutions in the United States, there have been numerous banks by this name that have been bought out, merged, or rebranded over the decades.
Howmet Aerospace Inc. (HWM) features exceptional growth momentum, with Wall Street analyst consensus price targets tracking strong multi-year upward revisions and upper-bound forecasts reaching high-tier valuations.
The S&P 500 Index (ticker: GSPC), which tracks the 500 largest publicly traded corporations listed on stock exchanges in the United States, represents a multi-trillion-dollar benchmark valuation rather than a single corporate stock.
GSK plc (LSE: GSK) is the stock representing the global biopharma giant GlaxoSmithKline, primarily listed on the London Stock Exchange. As of early August 2026, the company holds a market capitalization of approximately £104.76 billion.
GlaxoSmithKline manufactures an extensive and globally vital portfolio of prophylactic vaccines designed to protect populations against a wide variety of infectious diseases across different age groups.
Equity research analysts tracking GSK stock maintain a balanced consensus, often issuing moderate buy or hold ratings as the company navigates ongoing legal landscapes and executes its biopharma pipeline strategy.